BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17652658)

  • 1. Cancer and the constitution--choice at life's end.
    Annas GJ
    N Engl J Med; 2007 Jul; 357(4):408-13. PubMed ID: 17652658
    [No Abstract]   [Full Text] [Related]  

  • 2. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
    Moss RW
    New Sci; 2006 Jun 3-9; 190(2554):21. PubMed ID: 16832956
    [No Abstract]   [Full Text] [Related]  

  • 3. Access before approval--a right to take experimental drugs?
    Okie S
    N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
    [No Abstract]   [Full Text] [Related]  

  • 4. The terminally ill, access to investigational drugs, and FDA rules.
    Blake V
    Virtual Mentor; 2013 Aug; 15(8):687-91. PubMed ID: 23937785
    [No Abstract]   [Full Text] [Related]  

  • 5. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delicate balancing act.
    Nat Rev Drug Discov; 2007 Sep; 6(9):685. PubMed ID: 17907339
    [No Abstract]   [Full Text] [Related]  

  • 8. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
    Puckett A
    SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
    [No Abstract]   [Full Text] [Related]  

  • 9. Food and Drug Administration responds to pressure for expanded drug access.
    Brower V
    J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
    [No Abstract]   [Full Text] [Related]  

  • 10. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 11. Health roundup.
    Kennedy D
    Science; 2006 May; 312(5777):1105. PubMed ID: 16728598
    [No Abstract]   [Full Text] [Related]  

  • 12. The strange allure of state "right-to-try" laws.
    Zettler PJ; Greely HT
    JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
    [No Abstract]   [Full Text] [Related]  

  • 13. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?
    Orlando VI
    Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.
    Tsakopoulos A; Han J; Nodler H; Russo V
    Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigational drugs and the constitution.
    Dresser R
    Hastings Cent Rep; 2006; 36(6):9-10. PubMed ID: 17278864
    [No Abstract]   [Full Text] [Related]  

  • 18. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
    Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
    [No Abstract]   [Full Text] [Related]  

  • 19. Food and drug administration expanded access to treatment: implications for oncology patients.
    Freedman RS; Markman M
    Cancer; 2007 Jun; 109(11):2157-60. PubMed ID: 17450587
    [No Abstract]   [Full Text] [Related]  

  • 20. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.